Nuclear Medicine Market 2022 – Opportunities And Strategies – Global Forecast To 2030
The Business Research Company’s Nuclear Medicine Market 2022 – Opportunities And Strategies – Global Forecast To 2030
— The Business Research Company
LONDON, GREATER LONDON, UK, November 29, 2022 /EINPresswire.com/ — Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!
According to ‘Nuclear Medicine Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026’ published by The Business Research Company, the nuclear medicine market size is expected to reach a value of nearly $6.77 billion in 2022 at a compound annual growth rate (CAGR) of 12.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The nuclear medicine market is expected to grow to $11.20 billion in 2026 at a CAGR of 13.4%. The increasing constancy and prevalence of cardiovascular disease (CVD) and cancer are expected to propel the growth of the nuclear medicine market going forward.
Want to learn more on the nuclear medicine market growth? Request for a free Sample now.
The nuclear medicine market consists of sales of nuclear medicine and related products by entities (organizations, sole traders, and partnerships) that are used to assess the health of organs or tissue or to identify and remove any diseased or damaged organs or tissue. Nuclear medicine refers to a specialised area of radiology that uses radioactive material inside the body to inspect the overall health condition of the concerned patient. This branch of radiology is frequently used to identify and treat abnormalities that first appear very early in the course of a disease, such as thyroid cancer.
Global Nuclear Medicine Market Trends
Product innovation is the key trend gaining popularity in the nuclear medicine market. Major companies operating in the nuclear medicine market are focused on developing new innovative products to strengthen their position. For instance, in March 2021, GE Healthcare, a US-based company that deals with nuclear medicine, launched Star Guide, a new nuclear medicine system to assist in advancing precision health and theragnostics. StarGuide uses the most recent developments in Cadmium Zinc Telluride (CZT) technology to assist providers in exploring and better understanding the patient’s condition, enhancing patient outcomes throughout the continuum of care. It has unique features such as digital focus detectors and 360-degree imaging of the system that are intended to support improved theragnostic capabilities in nuclear medicine and advanced precision health.
Global Nuclear Medicine Market Segments
The global nuclear medicine market is segmented:
By Type: Diagnostic, Therapeutic
By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Application
By End-User: Hospitals and Clinics, Diagnostic Centers, Other End Users
By Geography: The global nuclear medicine market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America accounts for the largest share.
Read more on the global nuclear medicine market report here
Nuclear Medicine Global Market Report 2022 is one of a series of new reports from The Business Research Company that provides nuclear medicine global market analysis, nuclear medicine global market overviews, analyzes and forecasts market size and the global nuclear medicine market growth, nuclear medicine global market size, nuclear medicine global market segments and geographies, nuclear medicine global market players, nuclear medicine market leading competitor revenues, profiles and market shares. The nuclear medicine market report identifies top countries and segments for opportunities and strategies based on market trends and key competitors’ approaches.
TBRC’s Nuclear Medicine Global Market Report 2022 includes information on the following:
Data Segmentations: Market Size, Global, By Region and Country, Historic and Forecast, and Growth Rates for 60 Geographies
Key Market Players: Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd, Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organization, Cardinal Health Inc., GE Healthcare, Curium Pharma7
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
And so much more.
Looking for something else? Here is a list of similar reports by The Business Research Company:
Nanomedicine Global Market Report 2022
Nuclear Imaging Devices And Equipment Global Market Report 2022
Regenerative Medicine For Cartilage Market 2022
About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Check out our:
TBRC Blog: http://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The Business Research Company
+44 20 7193 0708
Visit us on social media: